Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update
Biomolecules · 03.05.2024 · 14 (5) · 552
DOI: 10.3390/biom14050552 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 03.05.2024. Verfasst von Michele Correale und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Department, Ospedali Riuniti University Hospital, 71100 Foggia, Italy. Hauptthemen laut MEDLINE: Biomarkers, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pulmonary arterial hypertension (PAH) is a rare subtype of group 1 pulmonary hypertension (PH) diseases, characterized by high pulmonary artery pressure leading to right ventricular dysfunction and potential life-threatening consequences. PAH involves complex mechanisms: vasoconstriction, vascular remodeling, endothelial dysfunction, inflammation, oxidative stress, fibrosis, RV remodeling, cellular hypoxia, metabolic imbalance, and thrombosis. These mechanisms are mediated by several pathways, involving molecules like nitric oxide and prostacyclin. PAH diagnosis requires clinical evaluation and right heart catheterization, confirming a value of mPAP ≥ 20 mmHg at rest and often elevated pulmonary vascular resistance (PVR). Even if an early and accurate diagnosis is crucial, PAH still lacks effective biomarkers to assist in its diagnosis and prognosis. Biomarkers could contribute to arousing clinical suspicion and serve for prognosis prediction, risk stratification, and dynamic monitoring in patients with PAH. The aim of the present review is to report the main novelties on new possible biomarkers for the diagnosis, prognosis, and treatment monitoring of PAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiothoracic Department, Ospedali Riuniti University Hospital, 71100 Foggia, Italy.
- Department of Medical and Surgical Sciences, University of Foggia, 71100 Foggia, Italy.
- Cardiothoracic Vascular Department, Division of Provincial Cardiology, Santissima Annunziata Hospital and Delta Hospital, Azienda Unità Sanitaria Locale di Ferrara, 44121 Ferrara, Italy.
- Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico, 00185 Rome, Italy.
- Department of Translational Medical Sciences, Federico II University, 80138 Naples, Italy.
- Department of Clinical and Molecular Medicine, Azienda Ospedaliera Sant'Andrea, "Sapienza" Università degli Studi di Roma, 00161 Rome, Italy.
ORCID-Profile: Michele Correale, Lucia Tricarico, Francesca Croella, Paolo Severino, Valentina Mercurio, Frank Dini, Roberto Licordari, Matteo Beltrami, Andrea Salzano, Alberto Palazzuoli
Zitieren
APA
Correale, M., Tricarico, L., Bevere, E. M. L., Chirivì, F., Croella, F., Severino, P., Mercurio, V., Magrì, D., Dini, F., Licordari, R., Beltrami, M., Dattilo, G., Salzano, A., & Palazzuoli, A. (2024). Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update. Biomolecules, 14(5), 552. https://doi.org/10.3390/biom14050552
Vancouver
Correale M, Tricarico L, Bevere EML, Chirivì F, Croella F, Severino P, et al. Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update. Biomolecules. 2024;14(5):552. doi:10.3390/biom14050552
BibTeX
@article{Correale2024,
author = {Correale, Michele and Tricarico, Lucia and Bevere, Ester Maria Lucia and Chirivì, Francesco and Croella, Francesca and Severino, Paolo and Mercurio, Valentina and Magrì, Damiano and Dini, Frank and Licordari, Roberto and Beltrami, Matteo and Dattilo, Giuseppe and Salzano, Andrea and Palazzuoli, Alberto},
title = {Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {5},
pages = {552},
doi = {10.3390/biom14050552}
}
EUVIMED